Cyclacel Pharmaceuticals, Inc. | Biopharmaceutical company developing cell cycle control cancer ther
Time 2020-10-06 13:04:21Web Name: Cyclacel Pharmaceuticals, Inc. | Biopharmaceutical company developing cell cycle control cancer ther
WebSite: http://www.cyclacel.com
ID:72388
Keywords:
Biopharmaceutical,company,Inc,biopharma,pharmaceutical,drug,discovery,research,dDescription:
Cell cycle pioneers improving patients healthcare with innovative medicines Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP) is a biopharmaceutical company developing innovative therapies that target various phases of cell cycle control for the treatment of cancer and other serious diseases. Our strategy is to build a diversified portfolio of novel drug candidates to address areas of high unmet medical needs. Our Pipeline Cyclacel is a pioneer in the field of cell cycle biology. Our vision is to improve patient healthcare by translating cancer biology into medicines. We have three programs in development: A transcriptional regulation program is evaluating lead asset CYC065, a dual inhibitor of cyclin dependent kinases (CDK) 2 and 9, in patients with advanced cancers. A mitosis regulation program is investigating CYC140, a polo-like kinase 1 inhibitor, in cancer patients. A DNA damage response program is evaluating a sequential regimen of sapacitabine and seliciclib, Cyclacel s first generation CDK inhibitor, in patients with BRCA positive, advanced solid cancers.Our clinical programs are enhanced through collaboration with world renowned cancer research organizations such as MD Anderson Cancer Center and Dana Farber Cancer Institute. Learn more about our clinical trials: CYC065 A highly-selective, orally-available, 2nd generation inhibitor of cyclin dependent kinases (CDK) 2 and 9. ASH 2019 Poster #1761 ASH 2019 Poster #1379 CYC140 A highly selective inhibitor of a mitotic pathway enzyme polo-like kinase 1. CYC682 (Sapacitabine) An oral nucleoside analogue prodrug that acts through a novel mechanism. ASH 2019 Poster #3926 details Common Stock Info NASDAQCM: CYCC US$ Price: Change: Delayed at least 20 minutes. Provided by Nasdaq. Interview of President & CEO Spiro Rombotis at the Biotech Showcase 2020, San Francisco (Video opens in a new window) New weapons in the battle against cancer. Scientists at Cyclacel Pharmaceuticals are turning the tables on cancer using cell cycle biology. Hear CEO Spiro Rombotis explain how these new approaches might keep cancer in check in this Cutting Edge Cast. Listen to the interview: Your browser doesn't support HTML5 audio. Here is a link to the audio instead. (You may need to adjust your computer's audio volume level.) Website created by Princeton Internet Group (PING) Sitemap | Privacy | Disclaimer | Contact Us | Alerting ServiceTAGS:Biopharmaceutical company Inc biopharma pharmaceutical drug discovery research d
<<< Thank you for your visit >>>
Cyclacel is a biopharmaceutical company, based in Berkeley Heights, New Jersey and Dundee, Scotland, that develops orally available small molecule drugs which target various cell cycle phases to control cancer and other serious diseases.Websites to related : Business Legal Resources - Huma
JavaScript seems to be disabled in your browser. You must have JavaScript enabled in your browser to utilize the functionality of this website. E
Music | Miracle Of SoundSorry, Bandcamp no longer supports the version of Internet Explorer that you're using (7.0). Please upgrade your browser to the latest version and try
Charter Boats UKCOVID-19 UPDATE If wish to book a fishing trip please contact boat skippers directly to get the latest infomration on whether or not they have any res
UK Bungee ClubThe Abyss @ Magna - The Drop Free-fall Experience 10th Oct 2020 The Abyss @ Magna - Sheffield / Rotherham The Drop - Free-fall ExperienceThe Drop - Fr
Center For Civil Justice - AdvocCCJ employs a variety of approaches to fight poverty and advocate for the needs and rights of low-income families. Through legal and political actions
Mercer Capital - Business ValDuring this time when the outlook for global markets, the economy, and one’s own health is uncertain, many trust company principals are working to na
Rubber stamps & Custom stamps, CCOVID-19 Notice (16/04/2020)We are OPEN as usualand are dispatching ordersdaily! We can usually ship within one business day. Due to the current Coron
International Journal of PharInternational Journal of Pharmacy and Pharmaceutical Sciences (Int J Pharm Pharm Sci) is peer-reviewed, monthly (Onward April 2014) open access Journa
Metaphysical MusingAnd to this day, [those] who...know the self as I am Brahman [the ONE], become all this universe. Even the gods [any other dimensional beings] canno
LinkedIn - Open for BusinessWelcome to LinkedIn for Small Business A place to grow your business on LinkedIn. Welcome to LinkedIn for small business. A place to grow your bu
adsHot Websites